课题基金 / 基金详情

Studies into Myeloperoxidase-Induced Cardiovascular Disease and its Treatment

Studies into Myeloperoxidase-Induced Cardiovascular Disease and its Treatment
髓过氧化物酶诱发的心血管疾病及其治疗的研究
批准号:
nhmrc : 1125392
负责人:
A/Pr Paul Witting
金额:
$59.78万
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2017
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2017-01-01 至 2021-12-31

项目摘要

项目成果

A/Pr Paul Witting的其他基金

相似基金

相关文献

中文摘要
翻译
在心血管疾病期间,一种名为髓过氧化物酶(MPO)的炎性蛋白会异常释放到循环血液中,并被输送到患病的血管中。我们的研究首次表明,循环中MPO水平的增加会促进动脉粥样硬化和主动脉瘤的发生。该项目将研究MPO如何促进炎性动脉疾病,并测试新药抑制这种破坏性蛋白和预防心血管疾病的能力。
英文摘要
During cardiovascular disease an inflammatory protein called myeloperoxidase (MPO) becomes abnormally released into the circulating blood and is transported into diseased blood vessels. Our studies show for the first time that increasing circulating levels of MPO promotes both atherosclerosis and aortic aneurysm. This project will study how MPO promotes inflammatory artery disease and test new drugs for their ability to inhibit this damaging protein and protect against cardiovascular disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Studies into Myeloperoxidase-Induced Cardiovascular Disease and its Treatment
  • 批准号:
    nhmrc : GNT1125392
  • 项目类别:
    Project Grants
  • 资助金额:
    $92.46万
  • 财政年份:
    2017
  • 负责人:
    A/Pr Paul Witting
  • 依托单位:
Redox Control of the Immune Regulatory Protein, Indoleamine 2,3-dioxygenase
  • 批准号:
    nhmrc : 1058508
  • 项目类别:
    Project Grants
  • 资助金额:
    $38.44万
  • 财政年份:
    2014
  • 负责人:
    A/Pr Paul Witting
  • 依托单位:
How is an important immune regulatory protein controlled?
  • 批准号:
    nhmrc : GNT1058508
  • 项目类别:
    Project Grants
  • 资助金额:
    $37.18万
  • 财政年份:
    2014
  • 负责人:
    A/Pr Paul Witting
  • 依托单位:
The Role of Snoring Vibrations in the Pathogenesis of Early Carotid Artery Atherosclerosis
  • 批准号:
    nhmrc : 570789
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $39.6万
  • 财政年份:
    2009
  • 负责人:
    A/Pr Paul Witting
  • 依托单位:
海外基金